Cytek Biosciences, Inc. (CTKB)
4.71
+0.09
(+1.95%)
USD |
NASDAQ |
Sep 09, 14:53
Cytek Biosciences Shareholders Equity (Quarterly) : 321.95M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 321.95M |
| March 31, 2026 | 327.64M |
| December 31, 2025 | 341.74M |
| September 30, 2025 | 378.57M |
| June 30, 2025 | 377.56M |
| March 31, 2025 | 379.62M |
| December 31, 2024 | 395.74M |
| September 30, 2024 | 385.46M |
| June 30, 2024 | 389.12M |
| March 31, 2024 | 392.61M |
| December 31, 2023 | 393.06M |
| September 30, 2023 | 415.52M |
| Date | Value |
|---|---|
| June 30, 2023 | 424.18M |
| March 31, 2023 | 423.46M |
| December 31, 2022 | 425.30M |
| September 30, 2022 | 416.45M |
| June 30, 2022 | 411.03M |
| March 31, 2022 | 407.24M |
| December 31, 2021 | 405.04M |
| September 30, 2021 | 402.88M |
| June 30, 2021 | 183.02M |
| March 31, 2021 | 179.25M |
| December 31, 2020 | 178.29M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 7.363B |
| Bio-Rad Laboratories, Inc. | 7.174B |
| Bruker Corp. | 2.381B |
| Danaher Corp. | 52.58B |
| Harvard Bioscience, Inc. | 7.418M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 446.93M |
| Total Liabilities (Quarterly) | 124.98M |
| Debt to Equity Ratio | 0.1093 |
| Current Ratio | 4.481 |
| Net Debt Paydown Yield | -0.30% |